Mighty Therapeutics – Grants, Sponsorships & Charitable Contributions (2026)
Funding for Medical Education, Patient Communities, Scientific Education, and Humanitarian Programs
Mighty Therapeutics supports programs and initiatives that provide healthcare professionals and patient communities with access to educational information about disease awareness, therapeutic management, and scientific advancements.
Funding is available through three distinct channels: independent medical education grants, organizational sponsorships, and charitable contributions. Requests should align with Mighty Therapeutics’ areas of interest in mitochondrial dysfunction and must be submitted at least 60 days before the proposed funding start date.
Organization: Mighty Therapeutics
Support Type: Medical education grants, organizational sponsorships, and charitable contributions
Geographic Focus: Not specifically limited; applicants should review the program requirements and applicable tax documentation
Application Timeline: Rolling / ongoing
New to corporate grant fundraising?
Read our Corporate Grants for Nonprofits: Ultimate Guide to learn how corporate funding works.
About the Funder
Mighty Therapeutics is a biotechnology company focused on mitochondrial medicine and developing therapies for diseases involving mitochondrial dysfunction.
Its funding program supports educational initiatives that expand access to information for healthcare providers and patient communities. The company prioritizes programs related to its therapeutic areas of interest and evaluates eligible requests individually.
What This Program Supports
Mighty Therapeutics offers three primary types of funding:
Independent Medical Education Grants
Independent Medical Education funding supports educational programs and activities for healthcare professionals that are developed and delivered by independent organizations.
Eligible providers may include:
- Hospitals
- Academic medical centers
- Universities
- Medical and scientific societies
- Professional associations
- Medical education companies
Programs should aim to improve:
- Disease management
- Patient health
- Patient safety
- Healthcare professional knowledge
Educational activities may be delivered through:
- Live presentations
- Written educational materials
- Online courses
- Conference symposia
- Other independent medical education formats
Funding is intended to educate broad audiences and may not be used to educate only one individual.
Organizational Sponsorships
Organizational Sponsorship Support may be available to non-healthcare organizations and associations.
Sponsorship funding may support:
- Medical education programs
- Organizational initiatives
- General non-commercial purposes
Supported activities must be unrelated to the promotion of Mighty Therapeutics’ investigational compounds or products.
Charitable Contributions
Charitable donations may be awarded to accredited institutions and organizations in support of philanthropic or fundraising activities.
Potential areas of support include:
- Humanitarian programs
- Social programs
- Scientific education
- Community awareness initiatives
Therapeutic Areas of Interest
Mighty Therapeutics focuses on mitochondrial dysfunction in the following areas:
Rare Genetic Disorders
Programs that increase understanding, education, and awareness related to rare genetic disorders involving mitochondrial dysfunction.
Neurodegenerative Disorders
Educational initiatives related to neurodegenerative diseases and the role of mitochondrial dysfunction.
Ophthalmic Disorders
Programs addressing eye diseases and other ophthalmic conditions related to the company’s scientific and therapeutic focus.
Applicants should clearly demonstrate how the proposed program aligns with one or more of these areas.
Eligibility & Preferences
Competitive requests should:
- Align with Mighty Therapeutics’ therapeutic areas of interest
- Provide value to patients or healthcare professionals
- Reach a broader audience rather than a single individual
- Be innovative
- Be cost-effective
- Include complete and accurate application materials
- Be submitted at least 60 days before the requested funding start date
Applications are evaluated individually and compared with other funding requests.
Previous support does not guarantee future funding.
Supporting Documentation
Applicants should submit a completed application or request form along with a cover letter describing the proposed request.
Depending on the type of request, supporting materials may include:
- Program agenda or brochure
- Detailed line-item budget
- Signed W-9, W-8, or W-8BEN-E form
- Needs assessment
- Learning objectives
- Outcomes measurement plan
For accredited continuing medical education programs seeking Independent Medical Education funding, applicants should also provide a copy of the applicable accreditation letter or certificate.
Ineligible or Uncompetitive Requests
Mighty Therapeutics does not publish a comprehensive list of excluded organizations or activities. However, requests are unlikely to be competitive when they:
- Seek funding to educate only one individual
- Do not align with the company’s therapeutic areas of interest
- Do not provide clear value to patients or healthcare professionals
- Are incomplete or missing required information
- Are submitted fewer than 60 days before the proposed funding start date
Organizational sponsorships should also be for non-commercial purposes unrelated to the promotion of Mighty Therapeutics’ investigational compounds or products.
Funding Amounts
Mighty Therapeutics does not publish standard grant, sponsorship, or charitable contribution amounts.
Funding decisions are based on the individual merits of each request and its relationship to other requests under consideration.
Applicants should provide a detailed, reasonable, and cost-effective budget appropriate to the proposed program.
Timeline & Review
📅 Application Timeline: Rolling / ongoing
📅 Required Lead Time: At least 60 days before the requested funding start date
📅 Review Process: Individual merit and comparison with other funding requests
📅 Decision Timing: Not published
Applicants should build additional time into their planning process and submit complete requests as early as possible.
Incomplete applications may result in processing delays.
Application / Request Process
The submission process depends on the type of funding requested.
Independent Medical Education Grants
Applicants should:
- Complete the grant application
- Prepare a cover letter describing the request
- Attach all appropriate supporting documentation
- Email the completed submission to grants@mightytx.com
Corporate Sponsorships & Charitable Contributions
Applicants should:
- Complete the applicable request form
- Prepare supporting materials describing the request
- Email the completed submission to sponsorship@mightytx.com
Applicants should review the current requirements and access the application materials through the official funding page.
Apply / Learn More:
➡️ Mighty Therapeutics Grants & Sponsorships
Why This Opportunity Is a Good Fit
This opportunity is a strong fit for organizations that:
- Provide independent medical education
- Serve healthcare professionals or patient communities
- Work in rare genetic, neurodegenerative, or ophthalmic disorders
- Focus on mitochondrial disease or mitochondrial dysfunction
- Develop scientific education or community awareness initiatives
- Can demonstrate broad educational reach
- Have a strong needs assessment and outcomes measurement plan
- Are seeking sponsorship or charitable support for aligned humanitarian or social programs
This program is particularly well suited for hospitals, academic institutions, medical societies, professional associations, medical education organizations, and other institutions with specialized expertise in the company’s therapeutic areas.
Corporate Grants Guide Notes
Review Type: Rolling; individual review
Required Lead Time: At least 60 days before the funding start date
Funding Amount: Not published
Therapeutic Focus: Rare genetic disorders, neurodegenerative disorders, and ophthalmic disorders involving mitochondrial dysfunction
Best Suited For: Medical education providers, healthcare institutions, professional associations, scientific organizations, and eligible organizations seeking aligned sponsorship or charitable support
Important Note: This is a specialized healthcare and medical education funding program, not a broad general-purpose nonprofit grant opportunity.
